NCT02085148 2024-04-22A Phase I Dose Finding Study in Children With Solid Tumors Recurrent or Refractory to Standard TherapyBayerPhase 1 Completed62 enrolled
NCT00101270 2013-06-05Oxaliplatin and Irinotecan in Treating Young Patients With Refractory Solid Tumors or LymphomasNational Cancer Institute (NCI)Phase 1 Completed24 enrolled